Poster Abstract Session:
70. Tuberculosis and Other Mycobacterial Infections
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID, Trainee, Transplant ID


Presentations:
752
Geographic Analysis of Latent Tuberculosis Screening: A Health System Approach
John Bonnewell, MD; Laura Farrow, BA; Kristen Dicks, MD, MPH; Gary Cox, MD; Jason E. Stout, MD, MHS
753
Screening for Latent Mycobacterium tuberculosis Infection (LTBI): A Clinical Conundrum of Public Health Concern
Lauren Bricker, PharmD; Jeff Brock, PharmD, MBA, BCPS-AQ ID; Jan Tippett, MSc; Casey Rice, MD; Jason Wittmer, MD; Alicia Crippen, RN; Ravi Vemuri, MD
Posters
  • IDWeek 2018 Bricker.pdf (148.2 kB)
  • 756
    Targeting the Birth-Cohort of the Pre-antibiotic Era;A Proposal to Screen for Tuberculosis in Seniors in Arkansas
    Mofan Gu, MPH; Lori Fischbach, PhD; Naveen Patil, MD MHSA MA; Joseph Bates, MD MS; Leonard Mukasa, MBChB PhD
    757
    Community Prevalence of Bacteriologically Confirmed Pulmonary Tuberculosis: A Seven Year Retrospective Study
    Nandini Sethuraman, MD; M.a Thirunarayan, MD; R Subbulakshmi, MD; V Lakshmisree, MD; Udhaya Balasubramanian, MD
    758
    Tuberculosis Recurrence in New York City: A Retrospective Study
    Tristan McPherson, MD; Lisa Trieu, MPH; Jeanne Sullivan Meissner, MPH; Shama Ahuja, PhD MPH; Joseph Burzynski, MD MPH
    Posters
  • IDWEEK_TB_RECURRENCE_FINAL.pdf (538.0 kB)
  • 760
    The Diversity of Mycobacterium tuberculosis in India is Underestimated and Underreported
    Husain Poonawala, MBBS; Amit Verma, PhD; Narender Kumar, PhD
    761
    Age related incidence of TB infection supporting efficacy of BCG vaccination
    Eileen Sweeney, Dr.; Darren Dahly, PhD; Nahed Seddiq, Dr.; Mary Horgan, MD; Dan Corcoran, Dr.; Corinna Sadlier, PhD
    Posters
  • IDSA poster Eileen Sweeney.pdf (607.1 kB)
  • 762
    Sex Differences in The Epidemiology of Tuberculosis in Tunisia
    Maissa Ben Jemaa, MD; Makram Koubaa, MD; Houda Ben Ayed, MD; Chakib Marrakchi, MD; Maroua Trigui, MD; Jamel Dammak, MD; Mounir Ben Jemaa, MD
    763
    Risk Factors for Homeless Status and Mortality among Homeless TB Cases in Texas, 2010-2017
    Saroochi Agarwal, PhD, MSPH; Duc T. Nguyen, MD, PhD; Edward A. Graviss, PhD, MPH, FIDSA
    Posters
  • homeless_TB_IDSA.pdf (2.0 MB)
  • 764
    Impact of Diabetes Mellitus on the Presentation and Response to Treatment of Adults with Pulmonary Tuberculosis in Qatar
    Khalid M. Dousa, FACP, FIDSA, CABIM; Abdelrahman Hamad, MD; Hussam Alsoub, Senior Consultant; Abdel-Naser Elzouki, MD; Mahmoud I. Alwakeel, MD; Bonnie A. Thiel, M.S.; John L. Johnson, M.D.
    765
    Tuberculosis and Diabetes Mellitus among Prison Inmates in Peru: Results of a National Survey, 2016
    Daniel Rojas-Bolivar, MD; Zheng Zhu, PhD; Yamilee Hurtado, PhD; Milagros Zavaleta, MSc; Jorge Sanchez, MD, MPH; Roman Jandarov, PhD; Jorge Alarcon, PhD; Moises Huaman, MD, MSc
    Posters
  • poster_idweek_final.pdf (31.1 kB)
  • 766
    Migration Flows and Increase of Extrapulmonary Tuberculosis in a Low Prevalence Setting: a Retrospective Analysis in Two Italian Centers
    Mirko Compagno, RESIDENT; Laura Campogiani, RESIDENT; Luigi Coppola, RESIDENT; Loredana Sarmati, Professor; Massimo Andreoni, Professor; Daniela Francisci, PROFESSOR; Lavinia Saraca, RESIDENT; Franco Baldelli, PROFESSOR
    767
    A seven-year retrospective study of pediatric tuberculosis in a third level hospital in Mexico City
    Napoleón González Saldaña, PhD; Mercedes Macías Parra, MD; Eduardo Arias De La Garza, MD; Diego Galvis Trujillo, MD; Salim Kuri Ayala, MD; Ernesto Rivera Macías, MD; José Iván Castillo Bejarano, MD
    768
    Epidemiological and Clinical Profile of Miliary Tuberculosis in Southern of Tunisia
    Maissa Ben Jemaa, MD; Makram Koubaa, MD; Houda Ben Ayed, MD; Chakib Marrakchi, MD; Maroua Trigui, MD; Fatma Hammami, MD; Mariem Ben Hmida, MD; Tarak Ben Jemaa, MD; Jamel Dammak, MD; Mounir Ben Jemaa, MD
    769
    An outbreak of multidrug-resistant tuberculosis, Minnesota 2016–2017
    Malini Desilva, MD, MPH; Nora Moore, MPH; Dzung Thai, MPH; Mary Beth Grimm, MPH; Nadya Sabuwala, RN, MPH; Milayna Brueshaber, ,; Sarah Gordon, MPH NREMT-B; Laura Andersen, MPH; Victoria Hall, DVM MS; Sean Buuck, MPH; Cynthia Hickman, MPH; Katie Stinebaugh, MPH; Benjamin Silk, PhD, MPH; Kayla Raz, MPH; Sarah Talarico, PhD, MPH; Jonathan Wortham, MD; Elisabeth Kingdon, MPH; Gina Pistulka, PhD, RN, MPH, APHN-BC; Krissie Guerard, MS; Lauren Cowan, PhD; James E. Posey, PhD; Paula M Snippes Vagnone, MT (ASCP); Joel McCullough, MD, MPH; Dean Tsukayama, MD; Rajal K Mody, MD MPH; Kristen Ehresmann, RN, MPH
    Posters
  • IDWEEK_2018 v8.pdf (229.2 kB)
  • 770
    Multi-drug resistant tuberculosis cases in Arkansas in 2017: A Tale of Two Threats
    Emily Weldon, BS; Naveen Patil, MD MHSA MA; Jan Voyles, BS; Sandra Chai, MD; Marsha Majors, BSN, RN; Leonard Mukasa, MBChB PhD
    Posters
  • MDR TB Poster_Emily_2018.pdf (1.4 MB)
  • 771
    Drug Resistance Tuberculosis (DR-TB), Comorbidities and Risk Factors Identified in a Prospective Multicenter Cohort Study in Indonesia
    Erlina Burhan, doctor; Banteng Wibisono, doctor; Retna Indah, doctor; Gede Ketut Sajinadiyasa, doctor; Bambang Riyanto, doctor; Tutik Kusmiati, doctor; Nugroho Susanto, doctor
    772
    Factors Associated with Healthcare Delay of Active Pulmonary Tuberculosis after Hospitalization
    Jaijun Han, MD; Se Yoon Park, MD; Jebyung Park, MD; So Young Lee, BSN; Gil Eun Kim, BSN; Yeon Su Jeong, BSN; Jin Hwa Kim, MSN; Eunyoung Lee, MD; Eun Jung Lee, MD; Shi Nae Yu, MD; Tark Kim, MD; Min Hyok Jeon, MD; Eun Ju Choo, MD; Tae Hyong Kim, MD, PhD
    773
    Statins decrease the risk of active tuberculosis: a propensity score-matched analysis
    Min-Chul Kim, MD; Sung-Cheol Yun, PhD; Sung-Han Kim, MD, PhD
    774
    Extrapulmonary Tuberculosis: impact of early diagnosis and treatment on mortality
    Saqib Walayat, MD; Talha Awwal, MD; Jimna Ren, PhD; John Farrell, MD
    Posters
  • EPT-poster.pdf (161.4 kB)
  • 775
    An Epidemiological Analysis of Patients with Multidrug-Resistant Tuberculosis among Tibetan Refugees in India
    Tenzin Desel, MBBS; Naonori Tsuda, MD; Tenzin Tsundue, MBBS; Rangjung Lingtsang, MBBS; Sonam Topgyal, MBBS/DCH; Akahito Sako, MD/MPH; Hidekatsu Yanai, MD/PhD; Tsetan Sadutshang, MBBS/MPH
    Posters
  • IDSA poster 2018 ver 4.9.pdf (1.4 MB)
  • 776
    Tuberculosis screening among people living with HIV in Arkansas: A Ryan White Program Evaluation
    Mofan Gu, MPH; Naveen Patil, MD MHSA MA; Lori Fischbach, PhD; Tiffany Vance, MBA; Charles Bedell, MD MPH; Leonard Mukasa, MBChB PhD
    777
    Ten Year Experience of Tertiary Hospital Regarding Epidemiology, Diagnostic Method, and Drug Resistance of Tuberculosis - Jeddah , Saudi Arabia
    Mohammed Qutub, PhD; Yasser Aldabbagh, Internal Medicine Resident; Prasanth Govindan, PhD; Ebtihal Alamoudi, Medical Student
    Posters
  • TB-Poster-IDWeek-2018-Final.pdf (323.7 kB)
  • 778
    Trend of tuberculosis meningitis and associated mortality in Texas, 2010-2017, a large population-based analysis
    Duc T. Nguyen, MD, PhD; Saroochi Agarwal, PhD, MSPH; Edward A. Graviss, PhD, MPH, FIDSA
    779
    Mycobacterium tuberculosis prosthetic joint infections: a case series and literature review
    Fabrice Uhel, MD; Grégory Corvaisier, MD; Yves Poinsignon, MD; Catherine Chirouze, MD; Guillaume Béraud, MD; Olivier Grossi, MD; Nicolas Varache, MD; Cédric Arvieux, MD; Rozenn Le Berre, MD, PhD; Pierre Tattevin, MD, PHD
    Posters
  • ID week 779.pdf (241.0 kB)
  • 780
    Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare, 2008-2015
    Kevin L. Winthrop, MD, MPH; Jennifer Adjemian, PhD; Mehdi Mirsaeidi, MD, MPH; Theodore Marras, MD, FRCPC, MSc; Gina Eagle, MD; Raymond Zhang, MBA; Ping Wang, PhD; Engels Chou, MS; Quanwu Zhang, PhD
    781
    Non Tuberculous Mycobacterium: Often a Missed Entity
    Sairam B, MBBS; Atul Gogia, MRCP(UK); Atul Kakar, DNB; S. P. Byotra, MBBS, MD
    782
    Risk Factors, Clinical Characteristic and Treatment Outcomes for Nontuberculous Mycobacterial Disease in Mexico
    Bruno Ali Lopez Luis, MD; Ma Teresa Perez-Gutierrez, MD; Miriam Bobadilla-Del-Valle, PhD; Alfredo Ponce-De-Leon, MD; José Sifuentes-Osornio, MD, FIDSA
    Posters
  • Poster ID Week SF 2018 NTM.pdf (989.3 kB)
  • 783
    Characterization of Non-tuberculous Mycobacteria Isolates in a National Mycobacterial Laboratory in Panama: 2012 - 2015.
    Sofia Zavala, MD; Samantha Rosas, MD; Arlene Calvo, MD; Nestor Sosa, MD; German Henostroza, MD; Ana Belen Arauz Rodriguez, MD
    Posters
  • Zavala_NTM.pdf (533.9 kB)
  • 784
    The Changing Epidemiology of Disseminated Mycobacterium avium complex in the U.S.
    Khalid M. Dousa, MD, FACP, CABIM; Rafael Ponce-Terashima, MD; Daniel Van Aartsen, MD; Alejandro De La Hoz, MD student; John L. Johnson, M.D.
    785
    Treatment of Mycobacterium immunogenum Skin and Soft Tissue Infections: A Case in a Peritoneal Dialysis Patient.
    Walid El-Nahal, MD; Abhishek Shenoy, MD; McCall Walker, MD; Tushar Chopra, MD; Greg Townsend, MD; Scott Heysell, MD, MPH; Joshua Eby, MD
    Posters
  • IDWEEK POSTER PDF.pdf (719.9 kB)
  • 786
    Ceftaroline and Avibactam? Is this a potential combination for Mycobacterium abscessus infection?
    Khalid M. Dousa, MD, FACP, CABIM; Barry N. Kreiswirth, PhD; Sebastian Kurz, MD, PhD; Robert A. Bonomo, MD
    789
    Comparison of Interferon-gamma Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients
    Prathit Kulkarni, M.D.; Joumana Kmeid, MD; Marjorie Batista, MD, PhD; Firas El Chaer, MD; Ella Ariza-Heredia, MD; Edward A. Graviss, PhD, MPH, FIDSA; Victor E. Mulanovich, MD; Roy F. Chemaly, MD, MPH, FIDSA, FACP
    790
    The efficacy of the interferon-gamma releasing assay-based isoniazid treatment for preventing active tuberculosis in kidney transplant recipients: a quasi-experimental study
    Hae-In Kim, MD; Kyeong Min Jo, M.D; Sungim Choi, M.D; Kyung Hwa Jung, MD; Jung Wan Park, MD; Ji Hyun Yun, MD; Min Jae Kim, MD; Yong Pil Chong, MD, PhD; Sang-Oh Lee, MD, PhD; Sang-Ho Choi, MD, PhD; Yang Soo Kim, MD, PhD; Jun Hee Woo, MD, PhD; Sung Shin, MD; Young-Hoon Kim, MD; Duck Jong Han, MD, PhD; Sung-Han Kim, MD, PhD
    791
    Hyponatremia Incidence and its Association with Mortality in Patients with Tuberculosis
    Andrea Llamas-Lopez, Internal Medicine Resident; Tania Vargas, Internal Medicine Resident; Luis Morales-Garza, M.D.; Rogelio Maya, M.D.
    Posters
  • IDSA.pdf (3.5 MB)
  • 794
    Infectivity of smear positive pulmonary TB after two weeks of rifampicin based anti tuberculous therapy
    Faraj Alhowady, MD; Nada Elmaki, MD, MRCP; Maisa Ali, MD, MRCP; Ahmad Husain, MD; Muna Al-Maslamani, MBBS, CABMS , MSc HCM -RCSI; Zubaida Alsuwaidi, Senior Clinical Scientist; Mahmoud Mohamed, MSc; Hussam Alsoub, Senior Consultant
    796
    Treatment of Latent Tuberculosis Infection in a Refugee Population
    Thomas Herchline, M.D., FIDSA; Ashley Trent, BS
    Posters
  • LTBI Poster w 2018-09-13.pdf (162.7 kB)
  • 797
    Tuberculosis Treatment: Combined Forms vs Dissociated Forms
    Maroua Trigui, MD; Makram Koubaa, MD; Houda Ben Ayed, MD; Chakib Marrakchi, MD; Fatma Hammami, MD; Tarak Ben Jemaa, MD; Jamel Dammak, MD; Mounir Ben Jemaa, MD
    798
    The role of whole genome sequencing in characterizing the mechanism of action of anti-tuberculosis compounds: demonstrated with para-amino salicylic acid and its analogue
    Giovanni Satta, MBBS MSc MBA FRCPath; Adam A Witney, PhD; Diepreye Ere, PhD; Alex Disney, PhD; Neelu Begum, MSc; Julio Ortiz Canseco, PhD; Colin Ratledge, PhD; Andrew N Boa, PhD; Timothy D McHugh, Professor
    Posters
  • Poster798.pdf (309.5 kB)
  • 800
    Drug resistant TB:An experience from Qatar
    Maisa Ali, MBBS; Faraj Alhowady, MBBS; Waqar Munir, MBBS; Muna Almaslamani, MBBS; Abdulatif Alkhal, MBBS; Zubiada Alswaidi, Ph.D. – Consultant Clinical Scientist; Hisham Ziglam, FRCP
    801
    Emergence of Multi-Drug Resistance Tuberculosis during the Treatment Course of Pan-Susceptible TB: A Case Series
    Mary Ford, MD; Kathryn Lago, DO; Quratulain Kizilbash, MD, MPH; Adriana Vasquez, MD
    802
    Use of N-acetylcysteine for prevention and treatment of isoniazid induced liver injury during treatment of mycobacterial infections
    Heidi Torres Diaz, MD; Ruth Serrano, MD; Jason E. Bowling, MD; Gregory Anstead, MD, PhD; Heta Javeri, MD, MPH
    Posters
  • NAC poster - id wk.pdf (629.9 kB)
  • 803
    Overcoming β-lactam Resistance in Mycobacterium abscessus
    Elizabeth Story-Roller, MD; Gyanu Lamichhane, PhD
    Posters
  • IDWeek 2018.ESR.803.pdf (3.6 MB)
  • 804
    Impact of Azithromycin Prophylaxis in Lung Transplant Recipients on the Risk of Nontuberculous Mycobacterial Infections
    Adrienne Workman, MD; Vaidehi Kaza, MD, MPH; Scott Bennett, MS; Pearlie Chong, MD, MSCR
    805
    Amikacin Liposome Inhalation Suspension (ALIS) Add-on Therapy for Refractory Mycobacterium avium Complex (MAC) Lung Disease: Effect of In Vitro Amikacin Susceptibility on Sputum Culture Conversion
    Barbara A. Brown-Elliott, MS, MT(ASCP)SM; Gina Eagle, MD; Richard J. Wallace, MD; Jakko Van Ingen, MD, PhD; Lian J. Pennings, Mr.; Brooke Berry, MBA; Sushil Pandey, PhD, MBA; Chris Coulter, MBBS, FRACP, FRCPA; Melanie Syrmis, PhD; Kevin L. Winthrop, MD, MPH; David E. Griffith, MD
    806
    2013-2015 Nationwide Tuberculosis Contact Investigation in Childcare Centers and Schools in Korea
    Woosuck Suh, M.D.; Jong-Hyun Kim, M.D., PhD; Ji Hyen Hwang, M.D.; Sodam Lee, MS; Kang-Hee Lee, M.D., PhD; Misun Park, PhD
    807
    A Risk-Stratified Approach to Healthcare-Associated Tuberculosis Exposures Following the "Stone in the Pond" Principle
    Dana E Pepe, MD, MPH; Michael Aniskiewicz, M(ASCP), CIC; George Paci, RN; Linda Sullivan, BSN, MBA, CIC; Louise-Marie Dembry, MD, MS, MBA, FSHEA; Richard Martinello, MD; Sonali Advani, MBBS, MPH;
    809
    Osteitis caused by Bacillus Calmette-Guerin Tokyo 172 strain in immunocompetent patients
    Napoleón González Saldaña, PhD; Mercedes Macías Parra, MD; Agustín De Colsa Ranero, MD; Eduardo Arias De La Garza, MD; Diego Galvis Trujillo, MD; José Iván Castillo Bejarano, MD
    810
    Diagnosis of BCG Aortitis by Plasma Metagenomic Sequencing
    Chris Cooper, MD; David Hong, MD; Lily Blair, PhD; Sivan Bercovici, PhD; Asim Ahmed, MD
    812
    Case Control trial to evaluate the Cytokine response to the use of Capsule Thalidomide in Erythema nodosum leprosum in leprosy patients
    Ajay Chopra, MD Dermatology; Debdeep Mitra, MD Dermatology; Barnali Mitra, MD Pediatrics
    813
    Combination of N-acetyl-cysteine with Clarithromycin against Mycobacterium avium infection
    Ayako Shiozawa, MD; Chiaki Kajiwara, PhD; Yoshikazu Ishii, PhD; Kazuhiro Tateda, PhD, MD
    Posters
  • ID week poster 2018.pdf (304.9 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.